drugset / Trial / NCT01606436
A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia
RandomizedCrossoverDouble-blindBasic science
Summary
This study determined if a single dose of LY2140023 (pomaglumetad methionil) affects the electrical activity in the heart in participants with schizophrenia. This study also helped determine how a single high dose of LY2140023 is tolerated by participants.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-08
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2140023 | Unknown | 400 mg | Oral |
| Subject | Moxifloxacin | Small molecule | 400 mg | Oral |